Sort
82,697 grants matching “vaccine development”
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$767,979Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2015 · CA
Posttranscriptional control of gene expression
$767,965Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa
$767,952Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · AI
Systems Biology of Mumps Vaccine Response
$767,943Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2018 · AI
R5 SHIV/Macaque Models for the Evaluation of T and B Cell-Based HIV-1 Vaccines
$767,830Cecilia C Cheng-Mayer · Aaron Diamond Aids Research Center · R01 · FY2011 · AI
Mucosal immunity and heterologous protection induced by single-cycle SIV
$767,746David T Evans · Harvard Medical School · P01 · FY2010 · AI
Revolutionary Eilat-based Chikungunya Vaccine Vector
$767,732Tian Wang · University Of Texas Med Br Galveston · R01 · FY2020 · AI
Defining Critical Sites of Vulnerability and Correlates of Protection to Kaposi Sarcoma Associated Herpesvirus to Inform Vaccine Design
$767,691Andrew McGuire · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
$767,673David C. Johnson · Oregon Health & Science University · R01 · FY2020 · AI
Predicting protective T-cell responses in Tuberculosis using a systems biology approach
$767,668Denise E Kirschner · University Of Michigan At Ann Arbor · R01 · FY2016 · AI
Mechanisms Of Protection of Universal Therapeutic Antibodies To Influenza A
$767,642Silke Paust · Baylor College Of Medicine · R01 · FY2018 · AI
Supramolecular pediatric HIV vaccine design
$767,636Genevieve Giny Fouda Amou Ou · Duke University · R01 · FY2021 · AI
Antibody-based therapeutic strategy for New World mammarenavirus hemorrhagic fever
$767,610Manuel L Penichet · University Of California Los Angeles · R01 · FY2023 · AI
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma
$767,578Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2025 · HL
Assessing ADCC and Fc-mediated Protection against HIV
$767,578David T Evans · University Of Wisconsin-Madison · R01 · FY2022 · AI
A Self-Adjuvanting Virus Like Particle Vaccine Platform for Emerging Viruses
$767,562Victor Robert Defilippis · Oregon Health & Science University · R01 · FY2023 · AI
Preventing HIV Transmission by Recently-Infected Drug Users
$767,500Samuel R Friedman · National Development And Research Institutes, Inc. · DP1 · FY2014 · DA
Modeling Filovirus Infection of and Trafficking through Skin
$767,437Wendy Jean Maury · University Of Iowa · R01 · FY2019 · AI
Development of Inhibitors Targeting Flavivirus Methyltransferase
$767,382Hongmin Li · University Of Arizona · R01 · FY2025 · AI
Development of Inhibitors Targeting Flavivirus Methyltransferase
$767,382Hongmin Li · University Of Arizona · R01 · FY2024 · AI
Development of Inhibitors Targeting Flavivirus Methyltransferase
$767,382Hongmin Li · University Of Arizona · R01 · FY2023 · AI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
$767,375Gaya K. Amarasinghe · Washington University · R01 · FY2025 · AI
Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
$767,375Gaya K. Amarasinghe · Washington University · R01 · FY2024 · AI
Functional genomic analysis of the CD8 T cell response to HIV vaccines in
$767,357William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2012 · AI
Functional genomic analysis of the CD8 T cell response to HIV vaccines in
$767,357William Nicholas Haining · Dana-Farber Cancer Inst · R01 · FY2014 · AI